Researchers develop an antibody that bridges T-cells to ovarian cancer cells, allowing the immune cell to eradicate ovarian tumors in preclinical models; currently being tested in Phase 1 trials. May have applications in other tumor types, such as pancreatic cancer, as well.

See the source article by following the link below:
Researchers develop an antibody that bridges T-cells to ovarian cancer cells, allowing the immune cell to eradicate ovarian tumors in preclinical models; currently being tested in Phase 1 trials. May have applications in other tumor types, such as pancreatic cancer, as well.